25I-NB3OMe

A synthetic psychedelic drug

25I-NB3OMe
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

25I-NB3OMe is a synthetic psychedelic compound belonging to the phenethylamine class. It is a derivative of the more well-known psychedelic 2C-I and is part of the NBOMe series of compounds, which are known for their potent effects at low doses.

Chemical structure and properties

25I-NB3OMe is chemically related to 2C-I, with the addition of a 2-methoxybenzyl group to the nitrogen atom of the ethylamine chain. This modification significantly increases the compound's potency compared to its parent compound. The presence of the iodine atom at the 4-position of the phenyl ring is a characteristic feature of this class of compounds.

Pharmacology

25I-NB3OMe acts primarily as a potent agonist of the 5-HT2A receptor, which is the primary target for most classical psychedelics. Activation of this receptor is responsible for the hallucinogenic effects experienced by users. The compound's high affinity for the 5-HT2A receptor makes it active at very low doses, which can increase the risk of overdose.

Effects

The effects of 25I-NB3OMe are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in thought processes. However, due to its high potency, the effects can be more intense and unpredictable. Users may experience both positive effects, such as euphoria and enhanced creativity, and negative effects, such as anxiety and paranoia.

Risks and safety

The use of 25I-NB3OMe carries significant risks, particularly due to its potency and the potential for overdose. Adverse effects can include tachycardia, hypertension, seizures, and in severe cases, death. The compound's safety profile is not well-established, and it is often sold as a "research chemical" with little information on safe dosing.

Legal status

The legal status of 25I-NB3OMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Users should be aware of the legal implications of possessing or distributing this compound.

Related pages

• 2C-I
• NBOMe series
• Psychedelic drug
• 5-HT2A receptor